Antibacterial Drugs Market Research Report Forecast to 2023

Transparency Market Research, in its latest report titled “Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, reveals that the global antibacterial drugs market is forecast to witness a rather slow growth from 2015 to 2023 owing to patent expiries of blockbuster drugs. Even though the market will register a meager CAGR of 1.30% during the forecast period, the value is anticipated to decline from US$43.9 bn in 2014 to US$38.9 bn in 2023.

This 110 page report gives readers a comprehensive overview of the Antibacterial Drugs Market. Browse through 9 data tables and 40 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/antibacterial-drugs-market.html

High prevalence of infectious diseases, government support and increased research and development activities, and product differentiation through various methods drive the antibacterial drugs market. However, rise in drug-resistant species, launch of generics, and upcoming patent expirations are anticipated to restrict the growth of the global market through 2023.The report offers a pipeline analysis of some of the key antibacterial drugs such as Zempia, Actoxumab/Aezlotoxumab, RHB-105, SYM-1219, Ozenoxacin, SPL7013, Cadazolid, Arikace, Surotomycin, Eravacycline, Carbavance, Delamanid, Omadacycline, Solithromycin, Ciprofloxacin/Fluocinolone Acetonide, Delafloxacin, and Plazomycin.

Based on drug class, the antibacterial drugs market is categorized into B-lactams, sulfonamides, macrolides, aminoglycosides, tetracyclines, quinolones/fluoroquinolones, phenicols, and miscellaneous antibacterials. Accounting for a share of 57.70% in the overall antibacterial drugs market in 2014, B-lactams dominated the scene. However, this drug class is anticipated to witness a drop in market share by 2023. The miscellaneous antibacterials category, on the other hand, is projected to develop at the highest growth rate from 2015 to 2023.

Get accurate market forecast and analysis on the Antibacterial Drugs Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1567

Geographically, the global antibacterial drugs market is segmented into North America, Asia Pacific, Latin America, Europe, and Rest of the World. Asia Pacific presently dominates the overall market and is also projected to witness the fastest growth over the duration of the forecast period. The Asia Pacific antibacterial drugs market is fueled by rising incidences of bacterial infections such as tuberculosis and MRSA, presence of large number of manufacturers of active pharmaceutical ingredient and generic drugs, rising purchasing power of the domestic population, expanding geriatric population, and developing healthcare infrastructure.

North America, followed by Europe, is the second largest regional market for antibacterial drugs in terms of revenue. These regions are anticipated to witness slow growth over the next seven years owing to stringent regulatory requirements, shortened product lifecycle, and generic infiltration.

The research report identifies and assesses the performance of the key players operating in the global antibacterial drugs market. These players are profiled based on attributes such as company and financial overview, business strategies, product portfolio, and recent developments. The companies featured in the antibacterial drugs market report are GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Pfizer, Inc., Sanofi, Johnson & Johnson, Bristol-Myers Squibb Company, AstraZeneca plc, Allergan plc (Actavis Plc), Bayer AG, and Eli Lilly and Company.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.